Header Logo

Connection

BINGBING DAI to Cyclin-Dependent Kinase Inhibitor p18

Back to Details
This is a "connection" page, showing publications BINGBING DAI has written about Cyclin-Dependent Kinase Inhibitor p18.
BINGBING DAI
Connection Strength
0.551
Cyclin-Dependent Kinase Inhibitor p18
  1. Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther. 2017 04; 16(4):662-670.
    View in: PubMed
    Score: 0.551
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.